Cancer Research Audrey Hepburn  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 995-1005, March 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lertratanangkoon, K.
Right arrow Articles by Scimeca, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lertratanangkoon, K.
Right arrow Articles by Scimeca, J. M.

Methyl-Donor Deficiency Due to Chemically Induced Glutathione Depletion1

Khingkan Lertratanangkoon2, Ralph S. Orkiszewski and Joseph M. Scimeca

Departments of Pharmacology and Toxicology [K. L.] and Pathology [J. M. S.], The University of Texas Medical Branch, Galveston, Texas 77555-1031, and Center for Experimental Therapeutics, Baylor College of Medicine, Houston, Texas 77030-3498 [R. S. O.]

Dietary deficiency of methionine (Met) is known to deplete cellular Met and cause DNA hypomethylation, but depletion of Met and impairment in methylation due to chemically induced glutathione (GSH) depletion has escaped recognition. In this study, the effect of GSH depletion on the Met pool and methylation capability was examined after bromobenzene (BB), a model GSH-depleting hepatotoxin, was administered to the Syrian hamster. An i.p. dose of BB (800 mg/kg) caused a rapid and extensive depletion of liver GSH; approximately 68% of the initial concentration was depleted during the first hour. The lowest level of GSH, only 4% of the control, was detected at 5 h. GSH depletion was accompanied by a prompt increase in liver Met during the first hour. This initial increase was followed by an extensive depletion during the next 4 h. At 5 h after BB, liver Met was 12% below the control value, and it remained around this concentration throughout the 24-h experiment. To further confirm these results, the endogenous Met pool was labeled with deuterated Met. The administration of L-Met-methyl-d3 to the Syrian hamster after GSH had been depleted by BB resulted in a significant protection of the liver against necrosis. The protection was accompanied by a marked incorporation of deuterated Met into the liver Met pool. The incorporation, which was determined by gas chromatography-mass spectrometry, shows BB dose dependence. Approximately 53% of the liver Met was labeled when a toxic BB dose (800 mg/kg) was used, while only 25% incorporation was found for the nontoxic dose (100 mg/kg). These results were different from the controls, where only 15% incorporation was found. The differences in the incorporation indicate that there are differences in the degree of utilization and/or depletion of Met in these hamsters, and these differences apparently are dependent upon the degree of toxicity and GSH depletion. The marked incorporation of deuterated Met in the high-dose group was accompanied with a striking increase in the methylation capability. Urinary excretion of the O- and S-methylated 4- and 5-bromo-2-hydroxythiophenols and S-methylated 4- and 5-bromo-2-hydroxy-1,2-dihydrobenzenethiols was significantly increased when compared with the BB treated alone. Approximately 40–45% of the methyl groups in these methylated BB metabolites were methyl-d3. These results provide direct evidence that depletion of GSH leads to Met depletion and also impairs the methylation processes.

1 Supported in part by NIH Grant ES-04857 (to K. L.).

2 To whom requests for reprints should be addressed, at Department of Pharmacology and Toxicology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1031.

Received 8/17/95. Accepted 1/ 3/96.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-F. Coppin, W. Qu, and M. P. Waalkes
Interplay between Cellular Methyl Metabolism and Adaptive Efflux during Oncogenic Transformation from Chronic Arsenic Exposure in Human Cells
J. Biol. Chem., July 11, 2008; 283(28): 19342 - 19350.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. K. Fukagawa and R. A. Galbraith
Advancing Age and Other Factors Influencing the Balance between Amino Acid Requirements and Toxicity
J. Nutr., June 1, 2004; 134(6): 1569S - 1574S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
Carcinogenesis, July 1, 2001; 22(7): 999 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Tao, S. Yang, M. Xie, P. M. Kramer, and M. A. Pereira
Effect of Trichloroethylene and Its Metabolites, Dichloroacetic Acid and Trichloroacetic Acid, on the Methylation and Expression of c-Jun and c-Myc Protooncogenes in Mouse Liver: Prevention by Methionine
Toxicol. Sci., April 1, 2000; 54(2): 399 - 407.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. C. Lind and A. J. Gandolfi
Hepatoprotection by Dimethyl Sulfoxide. I. Protection When Given Twenty-Four Hours After Chloroform or Bromobenzene
Toxicol Pathol, May 1, 1999; 27(3): 342 - 347.
[Abstract] [PDF]


Home page
J. Nutr.Home page
K. Lertratanangkoon, J. M. Scimeca, and J.-n. Wei
Inhibition of Glutathione Synthesis with Propargylglycine Enhances N-Acetylmethionine Protection and Methylation in Bromobenzene-Treated Syrian Hamsters
J. Nutr., March 1, 1999; 129(3): 649 - 656.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.